Thrombolysis of Pulmonary Embolism
The primary therapy for acute blood clots in the lungs has generally been the administration of the anticoagulation medications heparin and warfarin to prevent additional clotting. In about 50 percent of patients with pulmonary embolism, however, the clot is quite large and accompanied by at least one of several potentially compromising conditions. In many of these cases, particularly if there is evidence of low blood pressure, shock or severe respiratory failure, Swedish endovascular specialists may turn to clot-busting agents. These are delivered via an ultrasound accelerated system to save the patient’s life.
Management of Life-Threatening Bleeding
Swedish is a recognized leader in performing the endovascular procedures that prevent life-threatening blood loss. Injury to arteries and blood vessels as the result of trauma is an all-too-common occurrence, with the first priority always being to stop the bleeding as quickly as possible.
This task is often managed by standard surgical procedures, but there are times and conditions where a standard surgical approach will involve a significant amount of risk and, in fact, is less practical that a quickly performed endovascular procedure. This decision may depend on the exact site of the injury, as well as the vessel affected and whether the leakage that’s responsible for blood loss is causing a dilated blood vessel called a pseduoaneurysm. Also, the technique and material used to stop the blood loss will depend on the location and type of vessel that is injured and the future need to restore blood to the site.